Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/31/2001EP1040116A4 Functionalized pyrimidine derivatives
10/31/2001EP0975783B1 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells
10/31/2001EP0902780B1 Quaternary cytofectins
10/31/2001EP0842279B1 Helper viruses for preparing recombinant viral vectors
10/31/2001EP0815141B1 Antibodies active against a fusion polypeptide comprising a histidine portion
10/31/2001EP0803065B1 A-protein as a diagnostic of cancer
10/31/2001EP0779896B1 New process for the production of biologically active protein (tgf)
10/31/2001EP0717779B1 Method and device for detection of nucleic acid or analyte using total internal reflectance
10/31/2001EP0699077B1 Hiv immunogenic complexes
10/31/2001EP0637339B1 Dna constructs and plants incorporating them
10/31/2001EP0626998B1 Production of viral resistant plants via introduction of untranslatable plus sense viral rna
10/31/2001EP0604551B1 New cell line which supports replication of baculoviruses
10/31/2001EP0519001B1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
10/31/2001EP0444181B1 C-erbb-2 external domain: gp75
10/31/2001EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications
10/31/2001DE10020505A1 RSV NS Proteine antagonisieren die Interferon (IFN) Antwort RSV NS proteins antagonize the interferon (IFN) response
10/31/2001DE10020500A1 Vector system for transforming eukaryotic cells, useful in gene therapy or vaccination, comprises invasive bacteria containing bacterial artificial chromosome
10/31/2001DE10020138A1 Nukleinsäure codierend für zumindest eine raf Teilsequenz mit einer MEKK1 Bindungsstelle Nucleic acid coding for at least a part of raf sequence with a MEKK1 binding site
10/31/2001DE10019252A1 Polydesoxyribonukleotide zur Hemmung der ICAM-1-Genexpression Polydeoxyribonucleotides to inhibit the ICAM-1 gene expression
10/31/2001DE10019154A1 Zellbindende Nukleinsäuremoleküle (Aptamere) Cell-binding nucleic acid molecules (aptamers)
10/31/2001DE10019136A1 Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung Polyamide nucleic acid derivatives, means, and methods for their preparation
10/31/2001DE10019075A1 Verwendung von CD34 oder einem davon abgeleiteten Polypeptid als Zell-Oberflächen- bzw. Gentransfer-Marker Use of CD34 or a polypeptide derived as a cell-surface markers or gene transfer
10/31/2001DE10018022A1 Use of a lung surfactant composition to produce medicaments for the prophylaxis or early therapy of acute lung disorders in mammals
10/31/2001CN1320213A Surfaces with reduced electroosmotic flow
10/31/2001CN1320212A Method for detecting single nucleotide polymorphism (SNP) and point mutation in gene, detection apparatus and detection chip
10/31/2001CN1320167A An i(in vitro) activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase
10/31/2001CN1320165A Antithrombin nucleotides and proteins from horn fly
10/31/2001CN1320164A Novel collectin
10/31/2001CN1320163A Method for triggering apoptosis in cells
10/31/2001CN1320043A Mutant cholera holotoxin as an adjuvant
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1319671A Novel secretion expression vector and its application of recombinant hirudin expression technology
10/31/2001CN1319670A Foot-and-mouth disease virus gene engineered vaccine of domestic animal and preparation process thereof
10/31/2001CN1319669A Construction of vegetative period expression plasmid of bacillus thuringiensis cry IA (c) gene in waxy Bacillus
10/31/2001CN1319668A Nucleotide sequence of code dap C gene and process for producing L-lysine
10/31/2001CN1319667A Novel nucleotide sequence of code ptsH gene
10/31/2001CN1319666A Human testis development relative gene coding protein
10/31/2001CN1319665A Human testics kinesin 9 gene coding protein
10/31/2001CN1319664A Novel polypeptide--human glocosamine-6-phosphoisomerase 12 and polynucleotide for encoding said polypeptide
10/31/2001CN1319662A Human testicular ubiquitin specific proteinase-10 gene coding protein
10/31/2001CN1319660A Human testis specific protein kinase gene coding protein
10/31/2001CN1319659A Novel polypeptide-human lysyloxidase 33 and polynucleotide for encoding said polypeptide
10/31/2001CN1319658A Novel polypeptide--D-isomer specific 2-hydroxy acid dehydrogenase 30 and polynucleotide for encoding said polypeptide
10/31/2001CN1319612A Novel polypeptide-human scorpion short chain toxin protein 9 and polynucleotide for encoding said polypeptide
10/31/2001CN1319611A Novel polypeptide-human MAGE antigen 51 and polynucleotide for encoding said polypeptide
10/31/2001CN1319610A Novel polypeptide-human corticotrophin releasing factor 23 and polynucleotide for encoding said polypeptide
10/31/2001CN1319609A Novel polypeptide-human kinesin 9 and polynucleoitde for encoding said polypeptide
10/31/2001CN1319608A Novel polypeptide-human corticotrophin releasing factor 26 and polynucleotide for encoding said polypeptide
10/31/2001CN1319607A Novel polypeptide-human anky rin homoplastic protein 57 and polynucleotide for coding said polypeptide
10/31/2001CN1319606A Novel polypeptide-human actin formation regulator 30 and polynucleotide for encoding said polypeptide
10/31/2001CN1319605A Antitumour polypeptide and gene therapy vector composition
10/31/2001CN1319604A Novel polypeptide-ribosomal protein L15e25 and polynucleotide for encoding said polypeptide
10/31/2001CN1319603A Novel polypeptide-geminivirus motion protein 19 and polynucloetide for encoding said polypeptide
10/31/2001CN1319585A Process for refining amidate
10/31/2001CN1319356A Gene antibacterial piptide extracted from transgenic domestic fly-maggot used for foods putrefaction prevention and as freshness retaining agent for vegetable and fruit
10/30/2001US6310275 Artificially synthesized gene for trypsin inhibitor
10/30/2001US6310272 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same
10/30/2001US6310271 Increasing the stress resistance of plants to pathogens and pests by incorporating the polynucleotide molecule encoding a protein having choline monooxygenase activity into the plant genome to increase glycine betaine, an osmoprotectant; crops
10/30/2001US6310270 Endothelial NOS knockout mice and methods of use
10/30/2001US6310199 By adsorbing to the target nucleic acid at an adsorption ph and releasing the target nucleic acid at a desorption ph which is higher than the adsorption ph; magnetic silia particles; glycidyl ligands; amino acid ligands; spacers
10/30/2001US6310197 Nucleotide sequences for use in treatment of alzheimer's disease
10/30/2001US6310196 DNA construct for immunization or gene therapy
10/30/2001US6310195 Nucleic acid encoding a lectin-derived progenitor cell preservation factor
10/30/2001US6310194 Nucleotide sequences which code enzymatic polypetide; for use in controlling hydroxylation in transgenic plants
10/30/2001US6310192 SigB
10/30/2001US6310191 Generation of diversity in combinatorial libraries
10/30/2001US6310190 USPA1 and USPA2 antigens of Moraxella catarrhalis
10/30/2001US6310186 Purification of biological preparations
10/30/2001US6310184 Immunoglobulin for the treatment and prevention of mammary and prostate gland cancers
10/30/2001US6310182 Polypeptide for use in treatment of intracellular vesicular defects
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310176 Antimicrobially active polypeptides
10/30/2001US6310048 Antisense nucleotides coding given amino acid sequence of amyloid precursor protein (app) inhibit the expression of an amyloid beta protein (abp) portion of app while permitting expression of app polynucleotide 5' to the abp portion
10/30/2001US6310047 Forming a complex of an antisense oligodeoxynucleotide and a polynuclear platinum compound, and administering the complex to cells; treating cancer; platinum diamine complexes of given formula
10/30/2001US6310045 Compositions and methods for cancer immunotherapy
10/30/2001US6310044 Oligonucleotide therapies for modulating the effects of herpesviruses
10/30/2001US6310035 Plant cells, plants, and seeds expressing polypeptide having larvicidal activity
10/30/2001US6310034 Agouti polypeptide compositions
10/30/2001US6309891 Capillary printing systems
10/30/2001US6309883 Methods and compositions for cellular and metabolic engineering
10/30/2001US6309882 An antisense compound 8 to 30 nucleobases in length targeted to a nucleic acid encoding the human replication protein a p70 subunit, and inhibits the expression of the human replication protein a p70 subunit
10/30/2001US6309879 Human patched genes and proteins, and uses related thereto
10/30/2001US6309878 Glucose-inducible recombinant viral vector
10/30/2001US6309877 Polynucleotides encoding motoneuronotrophic factors
10/30/2001US6309876 Expression vector for propagation of cells in nervous system; for treating nervous system damage; gene therapy
10/30/2001US6309874 Selection marker
10/30/2001US6309873 Streptokinase mutants
10/30/2001US6309872 Polypeptides having glucoamylase activity and nucleic acids encoding same
10/30/2001US6309870 Phytase with a low michaelis constant (km) for phytic acid, which degrades phytic acid as an anti-rophic factor contained in animal feed to inositol and phosphoric acid, thus improves nutritive value by utilizing phoshoric acid released
10/30/2001US6309869 Polypeptides having acid phosphatase activity and nucleic acids encoding same
10/30/2001US6309868 Cloning of the prolyl-dipeptidyl-peptidase from Aspergillus oryzae
10/30/2001US6309867 Polypeptide; for use in controlling aging and cancer
10/30/2001US6309866 6-phosphogluconate dehydrogenase
10/30/2001US6309861 Process for the production of naturally folded and secreted proteins
10/30/2001US6309857 Nucleotide sequences coding preferential protein; for use in the treatment and prevention of cancer
10/30/2001US6309856 Human MAD proteins and uses thereof
10/30/2001US6309854 Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
10/30/2001US6309853 Nucleotide sequences coding polypeptide associated with contolling bdy weight; for use in diagnosis and treatment of eating disorders
10/30/2001US6309851 Generating genetically engineered polypeptide; transform cells, culture cells, recover genetically engineered polypeptide
10/30/2001US6309846 Evaluating humans with cancer; perform immunoassays over time to determine adjustment in preferential antigen concentration, ajustment in antigen concentration indicates adjustment in cancer classification
1 ... 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 ... 4023